Theodore Lagattuta

1.9k total citations
30 papers, 1.4k citations indexed

About

Theodore Lagattuta is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Theodore Lagattuta has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Theodore Lagattuta's work include Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Theodore Lagattuta is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Theodore Lagattuta collaborates with scholars based in United States, Jordan and Malaysia. Theodore Lagattuta's co-authors include Merrill J. Egorin, Joseph M. Covey, Julie L. Eiseman, Deborah R. Hamburger, Reginald F. Frye, Matthew Hruska, Annick Desjardins, James E. Herndon, James J. Vredenburgh and August J. Salvado and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Theodore Lagattuta

29 papers receiving 1.3k citations

Peers

Theodore Lagattuta

GENET

ONCOL

HEMAT

PRM

Ken Ohmine Japan

Feng Luo United States

Julie Litz United States

Sean Yoder United States

John Connelly United States

Shujun Lin China

Uma Yasothan United States

Toshiyuki Kitano Japan

Naoya Mimura Japan

Juthamas Sukbuntherng United States

Ken Ohmine Japan

Theodore Lagattuta

605 ×0.9

210 ×0.6

GENET

528 ×1.7

ONCOL

368 ×1.4

HEMAT

73 ×0.3

PRM

Citations per year, relative to Theodore Lagattuta Theodore Lagattuta (= 1×) peers Ken Ohmine

Countries citing papers authored by Theodore Lagattuta

Since Specialization

Citations

This map shows the geographic impact of Theodore Lagattuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore Lagattuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore Lagattuta more than expected).

Fields of papers citing papers by Theodore Lagattuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore Lagattuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore Lagattuta. The network helps show where Theodore Lagattuta may publish in the future.

Co-authorship network of co-authors of Theodore Lagattuta

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore Lagattuta. A scholar is included among the top collaborators of Theodore Lagattuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore Lagattuta. Theodore Lagattuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Zaiti, Salah S., et al.. (2025). 1463: EVALUATING HYPOXEMIA BURDEN AS A MORTALITY PREDICTOR IN STEP-DOWN UNITS. Critical Care Medicine. 53(1).

Kagiyama, Nobuyuki, Masataka Sugahara, Elizabeth Crago, et al.. (2019). Neurocardiac Injury Assessed by Strain Imaging Is Associated With In-Hospital Mortality in Patients With Subarachnoid Hemorrhage. JACC. Cardiovascular imaging. 13(2). 535–546. 17 indexed citations

Yousef, Khalil, Elizabeth Crago, Yue-Fang Chang, et al.. (2018). Vasopressor Infusion After Subarachnoid Hemorrhage Does Not Increase Regional Cerebral Tissue Oxygenation. Journal of Neuroscience Nursing. 50(4). 225–230. 6 indexed citations

Kagiyama, Nobuyuki, Elizabeth Crago, Masataka Sugahara, et al.. (2018). QUANTIFICATION OF REVERSE TAKOTSUBO PATTERN IN PATIENTS WITH SUBARACHNOID HEMORRHAGE BY LONGITUDINAL STRAIN. Journal of the American College of Cardiology. 71(11). A1464–A1464. 1 indexed citations

Yousef, Khalil, et al.. (2018). 3: GRADING SCALES IN SUBARACHNOID HEMORRHAGE: WHICH SCALE TO CONTROL FOR WHEN STUDYING OUTCOMES. Critical Care Medicine. 47(1). 2–2. 4 indexed citations

Yousef, Khalil, Elizabeth Crago, Theodore Lagattuta, & Marilyn Hravnak. (2017). Clinical Presentation to the Emergency Department Predicts Subarachnoid Hemorrhage-Associated Myocardial Injury. Journal of Emergency Nursing. 44(2). 132–138. 5 indexed citations

Reardon, David A., Merrill J. Egorin, Annick Desjardins, et al.. (2009). Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma. Cancer. 115(10). 2188–2198. 69 indexed citations

Reardon, David A., Annick Desjardins, James J. Vredenburgh, et al.. (2008). Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma. Neuro-Oncology. 10(3). 330–340. 33 indexed citations

Gibbons, Joseph, Merrill J. Egorin, Ramesh K. Ramanathan, et al.. (2008). Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group. Journal of Clinical Oncology. 26(4). 570–576. 106 indexed citations

10.

Gamblin, T. Clark, Merrill J. Egorin, Eleanor G. Zuhowski, et al.. (2007). Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas. Cancer Chemotherapy and Pharmacology. 62(4). 647–653. 17 indexed citations

11.

Russell, Michelle, et al.. (2007). Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk. Journal of Perinatology. 27(4). 241–243. 68 indexed citations

12.

Bernardi, Ronald J., Lisa Bomgaars, Elizabeth Fox, et al.. (2007). Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemotherapy and Pharmacology. 62(2). 355–361. 24 indexed citations

13.

Lin, Yong, Mecide Gharibo, Murugesan Gounder, et al.. (2007). Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors. Clinical Cancer Research. 13(19). 5876–5882. 27 indexed citations

14.

Wang, Yanfeng, et al.. (2006). Therapeutic Drug Monitoring of Imatinib and Impact on Clinical Decision Making.. Blood. 108(11). 4820–4820. 3 indexed citations

15.

Ramalingam, Sakkaraiappan, Theodore Lagattuta, Merrill J. Egorin, Michael Hayes, & Ramesh K. Ramanathan. (2004). Biliary Excretion of Imatinib Mesylate and Its Metabolite CGP 74588 in Humans. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(9). 1232–1235. 15 indexed citations

16.

Eiseman, Julie L., Jing Lan, Theodore Lagattuta, et al.. (2004). Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts. Cancer Chemotherapy and Pharmacology. 55(1). 21–32. 119 indexed citations

17.

Frye, Reginald F., et al.. (2004). Effect of St John's wort on imatinib mesylate pharmacokinetics. Clinical Pharmacology & Therapeutics. 76(4). 323–329. 176 indexed citations

18.

Egorin, Merrill J., Theodore Lagattuta, Deborah R. Hamburger, et al.. (2002). Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD 2 F 1 mice and Fischer 344 rats. Cancer Chemotherapy and Pharmacology. 49(1). 7–19. 141 indexed citations

19.

Mann, J. John, Ruth Henteleff, Theodore Lagattuta, et al.. (1996). Lower3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites. Journal of Neural Transmission. 103(11). 1337–1350. 43 indexed citations

20.

Mann, J. John, Victoria Arango, Ruth Henteleff, Theodore Lagattuta, & David T. Wong. (1996). Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal. Journal of Neural Transmission. 103(1-2). 165–171. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact